News Focus
News Focus
icon url

frrol

07/04/20 5:37 PM

#257602 RE: Doc328 #257570

You have doubts about the PDD trial overall, or just motor response?
icon url

frrol

07/04/20 5:45 PM

#257603 RE: Doc328 #257570

I'd have liked MMSE to have been as measurably responsive as the ADCS-ADL. With placebo controls the baseline for the latter can shift more and net benefit might not prove out. So we'll have to see.
icon url

blu_1

07/05/20 2:42 AM

#257625 RE: Doc328 #257570

So, 2-73 was most effective in subjects w/Apoe4, or in those lacking Apoe4?

High concentration group had higher frequency of Apoe4, so that may be why Apoe4 had the low p value, no?
icon url

blu_1

07/05/20 3:01 AM

#257627 RE: Doc328 #257570

If the high conc group had a normal incidence of Apoe4, do you think that group probably would have scored better?
icon url

bas2020

07/05/20 1:07 PM

#257692 RE: Doc328 #257570

I'm recalling from past presentations that ApoE4 was not a factor in the efficacy of 2-73. Several of the patients, expressing the ApoE4 gene, responded well to 2-73, at appropriate serum levels.